Home | Welcome to Contract Pharma   
Last Updated Monday, October 20 2014
Print

Breaking News

Related Searches:
April 14, 2010
AVEO Pharmaceuticals, Inc. has received a $5 million milestone payment from Biogen Idec International GmbH, a subsidiary of Biogen Idec, for the selection of the first humanized antibody development candidate from its ErbB3 program.  Read More »
April 14, 2010
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) received approval from the FDA for its NDA for Pancreaze (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or ot  Read More »
April 14, 2010
Baxter International and New York-Presbyterian Hospital/Weill Cornell Medical Center achieved positive results from an 18-month Phase II study of Gammagard Liquid and Gammagard S/D in mild-to-moderate Alzheimer’s disease.  Read More »
April 13, 2010
AMRI has entered a multi-year research collaboration with Navigen Pharmaceuticals focused on the development of new drug therapies.  Read More »
April 13, 2010
Patheon is adding development and manufacturing softgel capability at its Cincinnati facility.   Read More »
April 13, 2010
Mersana Therapeutics has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries to develop and commercialize XMT-1107, a novel fumagillin analog for the treatment of all indications, including cancer.  Read More »
April 13, 2010
Genzyme Corp. and Arecor Ltd. have entered an extensive collaboration agreement to develop advanced formulations for protein therapeutics.  Read More »
April 12, 2010
Guy Broadbent has been appointed president and chief executive officer of Xcellerex, Inc., as well as a member of the company’s board of directors.  Read More »
April 12, 2010
Almac, Merck KGaA, and UK-based Medical Research Council (MRC), have entered into a partnership to study metastatic colorectal cancer (mCRC) using samples from the MRC COIN trial.  Read More »
April 12, 2010
GE Healthcare achieved positive results from its multi-center Phase II study of flutemetamol, a positron emission tomography (PET) imaging agent for brain imaging.  Read More »
April 12, 2010
Javelin Pharmaceuticals, a specialty pharma in the pain management sphere, has received an acquisition bid from Discus, a subsidiary of Hospira, leading Javelin to cancel its previous merger agreement with Myriad Pharmaceuticals.   Read More »
April 9, 2010
Charles Bancroft has been appointed chief financial officer of Bristol-Myers Squibb.  Read More »
April 9, 2010
Penwest Pharmaceuticals and Alvogen, Inc. have signed a drug development and commercialization agreement under which the two companies will work to identify and select as many as five compounds for generic development.  Read More »
April 9, 2010
Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million.   Read More »
April 8, 2010
ADC drug expected to file in 1H11  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On